Prenatal management of placental mesenchymal dysplasia

Authors

DOI:

https://doi.org/10.31403/rpgo.v72i2865

Keywords:

placental mesenchymal dysplasia, aspirin, case report

Abstract

Introduction: Placental mesenchymal dysplasia (PMD) is a vascular condition associated with preeclampsia and intrauterine growth restriction (IUGR) due to placental thrombosis. Case Report: A pregnant woman diagnosed with PMD and a healthy fetus. After evaluating the thrombotic pathogenesis, it was decided to implement high-risk obstetric management, initiating prophylaxis with 150 mg of acetylsalicylic acid daily starting at 13 weeks. At 35 weeks, a cesarean section was performed due to premature rupture of membranes and oligohydramnios. Results: The fetal growth curve remained normal (40th–50th percentile). The mother did not develop preeclampsia during pregnancy or the postpartum period. The infant is developing normally at 14 months.

Downloads

Download data is not yet available.

Published

2026-10-05

Issue

Section

Casos Clínicos